Top Markets
Coin of the day
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Kedudukan dalam Saham #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Harga Saham
$3.45
Disegerakkan terakhir: 2021-09-21
Modal Pasaran
$4.29M
Perubahan (1 hari)
2.07%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan AzurRx BioPharma, Inc. (AZRX)

Kategori

Sejarah harga saham bagi AzurRx BioPharma, Inc. (AZRX)
Harga penutupan tertinggi: $5.04 pada 2021-09-01

Harga penutupan terendah: $50.52 pada 2016-10-01
Sejarah harga saham AzurRx BioPharma, Inc. dari 2016 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE